Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001:(3):CD002034.
doi: 10.1002/14651858.CD002034.

Biopsy versus resection for malignant glioma

S E Metcalfe  1 , R Grant
Affiliations

Biopsy versus resection for malignant glioma

S E Metcalfe et al. Cochrane Database Syst Rev. 2001.

Update in

  • Biopsy versus resection for high-grade glioma.
    Hart MG, Grant GR, Solyom EF, Grant R. Hart MG, et al. Cochrane Database Syst Rev. 2019 Jun 6;6(6):CD002034. doi: 10.1002/14651858.CD002034.pub2. Cochrane Database Syst Rev. 2019. PMID: 31169915 Free PMC article.

Abstract

Background: Patients with isolated supratentorial brain tumours, presumed to be primary on imaging, have two surgical management options - biopsy or resection. Surgical opinions appear to be equally divided when considering the relative risks and benefits of these two procedures.

Objectives: To estimate the clinical effectiveness of radical surgical resection compared to simple biopsy in patients with malignant glioma.

Search strategy: Electronic database searches of COCHRANE CONTROLLED TRIALS REGISTER (including the Cochrane Cancer Network Specialised Register of Trials), MEDLINE, CANCERLIT, EMBASE, BIOSIS and SCIENCE CITATION INDEX. Hand searching the references of all identified studies; hand searching the Journal of Neuro-Oncology over the previous 10 years, including all conference abstracts; personal communication.

Selection criteria: Randomised and clinical controlled trials were included if they compared biopsy to resection, or looked at effect of extent of resection on survival, time to progression or quality of life, for malignant glioma patients of all ages.

Data collection and analysis: Studies were to be identified, critically appraised and data extracted by the author (SEM). Ideally hazard ratios for overall survival were to be calculated along with the estimates of odds ratios from the percentage survival at one and two years. For dichotomous data, Peto odds ratios (OR) with 95% confidence intervals (CI) were hoped to have been estimated. Normal continuous data were to have been summated using the weighted mean difference (WMD).

Main results: The electronic database search yielded 2100 citations. Of these, two articles were identified for possible inclusion, however both were excluded. The hand search and personal communication were similarly unproductive. No studies were included in the review and no data was synthesised.

Reviewer's conclusions: Given that no qualifying studies were identified and because this is an important issue, both in terms of patient risk and benefit and health economics, the authors feels it important to conduct a randomised controlled trial in this subject.

PubMed Disclaimer

Update of

Publication types

LinkOut - more resources